Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease
This educational symposium was held during the Joint Congress of European Neurology (EFNS–ENS), which took place from 31st May to 3rd June 2014 in Istanbul, Turkey, and was sponsored by Britannia Pharmaceuticals Limited. The symposium debated the problem of delayed ON and OFF periods in Parkinson’s...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2014-07-01
|
Series: | European Medical Journal Neurology |
Subjects: | |
Online Access: | http://emjreviews.com/wp-content/uploads/Apomorphine-Penject-%E2%80%93-Emerging-Evidence-And-Treatment-Strategies-For-Delayed-On-And-Off-Periods-In-Parkinson%E2%80%99s-Disease.pdf |
id |
doaj-bba2a90c9d784db2a216bfec5929859d |
---|---|
record_format |
Article |
spelling |
doaj-bba2a90c9d784db2a216bfec5929859d2020-11-24T21:14:39ZengEuropean Medical JournalEuropean Medical Journal Neurology2054-45292014-07-01212735Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s diseaseOlivier Rascol0Fabrizio Stocchi1Stuart Isaacson2William Ondo3Professor, Toulouse University Hospital Clinical Investigation Centre, Toulouse, FranceProfessor, Institute of Research and Medical Care, IRCCS San Raffaele, Rome, ItalyAssociate Professor, Florida International University, Herbert Wertheim College School of Medicine, Miami; Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton; Research Director, Marcus Neuroscience Institute, Boca Raton Regional Hospital, Florida, USAProfessor, University of Texas Health Science Center, Houston, Texas, USAThis educational symposium was held during the Joint Congress of European Neurology (EFNS–ENS), which took place from 31st May to 3rd June 2014 in Istanbul, Turkey, and was sponsored by Britannia Pharmaceuticals Limited. The symposium debated the problem of delayed ON and OFF periods in Parkinson’s disease that can occur even in patients optimised on oral medication. Emerging evidence for the rapid and effective resolution of such complications using apomorphine intermittent injection (penject) was reviewed with particular reference to the positive results of the recent AM IMPAKT trial in patients with morning akinaesia. The discussions were illustrated with examples of ‘real life’ patient case studies to help determine which patients might be best suited for treatment with apomorphine injection.http://emjreviews.com/wp-content/uploads/Apomorphine-Penject-%E2%80%93-Emerging-Evidence-And-Treatment-Strategies-For-Delayed-On-And-Off-Periods-In-Parkinson%E2%80%99s-Disease.pdfEFNSENSEuropean Federation of Neurological SocietiesEuropean Neurological Society |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Olivier Rascol Fabrizio Stocchi Stuart Isaacson William Ondo |
spellingShingle |
Olivier Rascol Fabrizio Stocchi Stuart Isaacson William Ondo Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease European Medical Journal Neurology EFNS ENS European Federation of Neurological Societies European Neurological Society |
author_facet |
Olivier Rascol Fabrizio Stocchi Stuart Isaacson William Ondo |
author_sort |
Olivier Rascol |
title |
Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease |
title_short |
Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease |
title_full |
Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease |
title_fullStr |
Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease |
title_full_unstemmed |
Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease |
title_sort |
apomorphine penject – emerging evidence and treatment strategies for delayed on and off periods in parkinson’s disease |
publisher |
European Medical Journal |
series |
European Medical Journal Neurology |
issn |
2054-4529 |
publishDate |
2014-07-01 |
description |
This educational symposium was held during the Joint Congress of European Neurology (EFNS–ENS), which took place from 31st May to 3rd June 2014 in Istanbul, Turkey, and was sponsored by Britannia Pharmaceuticals Limited. The symposium debated the problem of delayed ON and OFF periods in Parkinson’s disease that can occur even in patients optimised on oral medication. Emerging evidence for the rapid and effective resolution of such complications using apomorphine intermittent injection (penject) was reviewed with particular reference to the positive results of the recent AM IMPAKT trial in patients with morning akinaesia. The discussions were illustrated with examples of ‘real life’ patient case studies to help determine which patients might be best suited for treatment with apomorphine injection. |
topic |
EFNS ENS European Federation of Neurological Societies European Neurological Society |
url |
http://emjreviews.com/wp-content/uploads/Apomorphine-Penject-%E2%80%93-Emerging-Evidence-And-Treatment-Strategies-For-Delayed-On-And-Off-Periods-In-Parkinson%E2%80%99s-Disease.pdf |
work_keys_str_mv |
AT olivierrascol apomorphinepenjectemergingevidenceandtreatmentstrategiesfordelayedonandoffperiodsinparkinsonsdisease AT fabriziostocchi apomorphinepenjectemergingevidenceandtreatmentstrategiesfordelayedonandoffperiodsinparkinsonsdisease AT stuartisaacson apomorphinepenjectemergingevidenceandtreatmentstrategiesfordelayedonandoffperiodsinparkinsonsdisease AT williamondo apomorphinepenjectemergingevidenceandtreatmentstrategiesfordelayedonandoffperiodsinparkinsonsdisease |
_version_ |
1716746462332715008 |